doulei

Personal Information:

Gender:Female
Date of Employment:2016-01-06

VIEW MORE
Home > Scientific Research > Paper Publications

Cost-effectiveness analysis of serplulimab plus chemotherapy in the first-line treatment for PD-L1-positive esophageal squamous cell carcinoma in China

Date of Publication:2023-05-04 Hits:

Affiliation of Author(s):卫生管理与政策研究中心
Journal:Frontiers in Immunology
First Author:刘世贤
Document Code:1A62E71633BF49E4821F0B68962B4011
Issue:14
Number of Words:4
Translation or Not:no
Date of Publication:2023-05-04